07/03/2025
7:02 AM | CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
7:00 AM | Cellectar Biosciences (Issuer)
Kolean Chad J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
7:01 AM | Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
06/30/2025
7:29 AM | Cellectar Biosciences (Filer)
| Form S-1/A | |
06/26/2025
8:26 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
8:22 AM | Cellectar Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/25/2025
4:22 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
3:45 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
8:26 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:02 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for CLRB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
5:04 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
3:36 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
04/28/2025
3:31 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
04/28/2025
3:32 PM | Cellectar Biosciences (Filer)
| Form ARS | |
03/17/2025
3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
5:50 AM | Cellectar Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2025
8:44 PM | Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
2:49 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
02/03/2025
3:57 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
9:07 AM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025
5:01 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
8:05 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
5:46 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
3:53 PM | Cellectar Biosciences (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/01/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
4:03 PM | Cellectar Biosciences (Filer)
| Form 10-Q/A | |
10/29/2024
4:09 PM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:56 PM | Cellectar Biosciences (Filer)
| Form 10-K/A | |
08/23/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:15 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
08/13/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
07/23/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
4:37 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
07/11/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Something very strange is happening... (Ad) What a "Mar-a-Lago Accord" could mean for the U.S. dollar
While protests dominate the news... hardly anyone noticed when the U.S. Senate granted sweeping powers to a Harvard economist who has some dangerous ideas about the U.S. dollar. Now, he's issued a blueprint for what a coming "Mar-a-Lago Accord" could look like. One analyst who predicted the 2008 crisis says this plan could see the dollar fall in value by 40% in months and become a national nightmare. why you need to get OUT of cash and exactly where to move your money instead. |
Free CLRB Stock Alerts